Nova Eye Medical Limited is an Australia-based medical technology company. The Company’s principal activities include design, development, service and marketing, sales, and distribution of medical devices to treat eye disease. The Company’s segments include 2RT and Glaucoma surgical devices. The Company's 2RT is an ophthalmic laser developed for the therapy of patients in the early to intermediate stages of age-related macular degeneration (AMD). Its technology includes the iTrack portfolio of canaloplasty devices for the treatment of glaucoma. iTrack minimally invasive glaucoma surgery (MIGS) is an implant-free, tissue-sparing device. iTrack is performed via an ab-externo approach to offer a bleb-free alternative to traditional glaucoma surgery in the treatment of advanced glaucoma patients. The Company also manufactures and sells the proprietary Molteno3 glaucoma drainage device for the treatment of severe or complex glaucoma.